Assessment of permanent hearing impairment following radical megavoltage radiotherapy.
Twenty patients who had received unilateral radical megavoltage radiotherapy to the temporal bone had their hearing assessed by pure tone audiometry between 2 and 16 years after completion of treatment. Hearing loss was not detected in the irradiated ear when compared with the non-irradiated ear of each patient.
Evans
R A
RA
Department of Otolaryngology, Victoria Infirmary, Glasgow.
Liu
K C
KC
Azhar
T
T
Symonds
R P
RP
D008949:Adenoma, Pleomorphic / Q000532:radiotherapy; D000328:Adult; D000368:Aged; D002277:Carcinoma / Q000532:radiotherapy; D005260:Female; D034381:Hearing Loss / Q000209:etiology*; D006801:Humans; D008297:Male; D008875:Middle Aged; D010307:Parotid Neoplasms / Q000532:radiotherapy; D011882:Radiotherapy, High-Energy / Q000009:adverse effects*